Ketamine Treatment for Pediatric Refractory Obsessive: Five Open Label Cases.
Journal of Child and Adolescent Psychopharmacology April 1, 2025 Hannah S Ishimuro, Paula K Yanes-Lukin, Pablo H Goldberg et al. 6 citations
Importance: Selective serotonin reuptake inhibitors (SSRIs) and cognitive behavioral therapy are the first-line treatments for pediatric obsessive-compulsive disorder (OCD) populations. Due to their limited effectiveness, additional treatment options are needed. A new potential pharmacological medication treatment avenue for OCD is intravenous (IV) ketamine. Objective: This study aimed to...